KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Boston Scientific (BSX) Acquisitions (2016 - 2025)

Historic Acquisitions for Boston Scientific (BSX) over the last 16 years, with Q4 2025 value amounting to $89.0 million.

  • Boston Scientific's Acquisitions fell 9739.61% to $89.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $1.6 billion, marking a year-over-year decrease of 6566.81%. This contributed to the annual value of $1.6 billion for FY2025, which is 6566.81% down from last year.
  • Latest data reveals that Boston Scientific reported Acquisitions of $89.0 million as of Q4 2025, which was down 9739.61% from $256.0 million recorded in Q3 2025.
  • Over the past 5 years, Boston Scientific's Acquisitions peaked at $3.4 billion during Q4 2024, and registered a low of $47.0 million during Q1 2024.
  • In the last 5 years, Boston Scientific's Acquisitions had a median value of $509.0 million in 2023 and averaged $740.2 million.
  • Data for Boston Scientific's Acquisitions shows a peak YoY increase of 200208.33% (in 2025) and a maximum YoY decrease of 9739.61% (in 2025) over the last 5 years.
  • Boston Scientific's Acquisitions (Quarter) stood at $244.0 million in 2021, then crashed by 70.9% to $71.0 million in 2022, then skyrocketed by 1016.9% to $793.0 million in 2023, then soared by 331.02% to $3.4 billion in 2024, then plummeted by 97.4% to $89.0 million in 2025.
  • Its Acquisitions stands at $89.0 million for Q4 2025, versus $256.0 million for Q3 2025 and $1.0 billion for Q2 2025.